RLMD
Relmada Therapeutics, Inc. · Healthcare
CEO Sergio Traversa bought $116K of Relmada Therapeutics, Inc.
Bought$115,804
$2.10Price
55,250Shares
+62%Stake
What RLMD did for a copier
- $1,000 copied at Mon, Dec 12 close, $3.39
- $1,236
- S&P 500, same days
- +1.9%
Measured over 30 trading days, to the Jan 26 close.
Sergio Traversa's record
6 other buys with 3 months of prices since 2024: on average +69.5% against the S&P 500, and 3 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Dec 8. Filed Mon, Dec 12, 3:00 PM ET, during the session. Returns use the Dec 12 close and the Jan 26 close. Not investment advice.